
GW6340
CAS No. 405910-78-3
GW6340( —— )
Catalog No. M36854 CAS No. 405910-78-3
GW6340 is a selective LXR agonist with potential anticancer activity that promotes macrophage reverse cholesterol transport (mRCT) and can be used to study atherosclerosis.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 52 | In Stock |
![]() ![]() |
5MG | 72 | In Stock |
![]() ![]() |
10MG | 125 | In Stock |
![]() ![]() |
25MG | 256 | In Stock |
![]() ![]() |
50MG | 430 | In Stock |
![]() ![]() |
100MG | 700 | In Stock |
![]() ![]() |
500MG | 1413 | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameGW6340
-
NoteResearch use only, not for human use.
-
Brief DescriptionGW6340 is a selective LXR agonist with potential anticancer activity that promotes macrophage reverse cholesterol transport (mRCT) and can be used to study atherosclerosis.
-
DescriptionGW6340 is an intestinal-specific LXR agonist. GW6340 promotes macrophage reverse cholesterol transport (mRCT).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorLiver X Receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number405910-78-3
-
Formula Weight581.07
-
Molecular FormulaC33H32ClF3N2O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (172.10 mM; Ultrasonic )
-
SMILESO=C(N)CC=1C=CC=C(OCCCN(CC2=CC=CC(=C2Cl)C(F)(F)F)CC(C=3C=CC=CC3)C=4C=CC=CC4)C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Yasuda T, et al. Tissue-specific liver X receptor activation promotes macrophage reverse cholesterol transport in vivo. Arterioscler Thromb Vasc Biol. 2010 Apr;30(4):781-6.?
molnova catalog



related products
-
Pritumumab
Pritumumab (ACA 11) is a natural human IgG1 κ antibody that can be used to study glioblastoma and brain tumors.
-
3-(2-Hydroxyphenyl)-...
3-(2-Hydroxyphenyl)-2-propenal is a natural product for research related to life sciences.
-
Theaflavine-3,3'-dig...
Theaflavine-3, 3'-digallate and lactic acid together could reduce herpes simplex virus transmission.